FDA adds warning about rare reaction to J&J COVID-19 vaccine

They're pushing for more funding to find effective treatments. Researchers are finally starting to make headway but have a way to go.

As of September 10, all mammogram centers and providers are required to inform patients if they have dense breast tissue, which can make screening more difficult.

J&J said it filed a request with the FDA to authorize boosters for people 18 and older who previously received the company's one-shot vaccine.